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Conclusions. OSM is a frequent finding in adult patientsBone histology in patients with nephrotic syndrome and normal
with NS, even at a normal level of renal function. Its severityrenal function.
correlates with the amount and duration of proteinuria.Background. The prevalence of metabolic bone disease in
patients with nephrotic syndrome (NS) at normal level of renal
function remains uncertain.
Methods. To address this issue, we studied 30 patients (20 Nephrotic syndrome (NS), when persistent, often re-men and 10 women, mean age 27.3 6 11.7 years) with NS who
sults in a number of biochemical and metabolic distur-had normal renal function (mean creatinine clearance 103 6
bances. These are mainly attributed to the loss of a vari-4 ml/min). We evaluated their serum calcium, phosphorus,
alkaline phosphatase, immunoreactive parathyroid hormone ety of plasma proteins and minerals in the urine [1].
(iPTH), vitamin D metabolites, urinary calcium, and skeletal Abnormalities of calcium metabolism in patients with
survey. The extent of bone mineralization was analyzed by NS are well recognized. Although the onset of renalhistomorphometric analysis of iliac crest bone biopsy speci-
insufficiency may contribute, these abnormalities may bemens in all patients. The findings on bone histology were corre-
found at a normal level of renal function [2–7]. The serumlated with biochemical parameters.
Results. The mean duration of NS was 35.5 6 26.9 months, concentration of 25-hydroxyvitamin D [25(OH)D] is
with a protein excretion of 7.3 6 3.2 g/24 hr and a serum lowered in patients with NS because of a loss of vitamin
albumin of 2.2 6 0.8 g/dl. Total serum calcium was 7.8 6 0.8
D-binding protein in the urine [4, 8, 9]. Alteration in themg/dl, whereas ionized calcium was 5.7 6 0.7 mg/dl, phosphorus
level of circulating 1,25-dihydroxyvitamin D [1,25(OH)2D],3.2 6 1.2 mg/dl, and alkaline phosphatase 149 6 48.6 U/liter.
Serum iPTH levels were normal in all except two patients. The which shares the same carrier protein, has also been
mean serum 25-hydroxyvitamin D [25(OH)D] level was 3.9 6 reported [2, 3, 9, 10]. Hypocalcemia and hypocalciuria,
1.2 ng/ml (normal 15 to 30 ng/ml), whereas 1,25-dihydroxyvita- attributed to the previously mentioned disturbances in
min D was 24 6 4.7 pg/ml (normal 16 to 65). There was an
vitamin D metabolism, are common features in theseinverse correlation between serum levels of 25(OH)D and the
patients [11, 12]. Intestinal calcium absorption has beenmagnitude of proteinuria (r 5 20.42, P , 0.05). The mean 24-
hour urinary calcium excretion was 82 6 21 mg/day. The skele- found to be low in metabolic balance studies [12] but
tal survey was normal in all patients. Bone histology was normal normal when measured with radiocalcium [2]. However,
in 33.3% of the patients, whereas 56.7% had isolated osteoma- low ionized serum calcium resulting in an increased levellacia (OSM), and 10% had an increased bone resorption in
of circulating immunoreactive parathyroid hormoneassociation with defective mineralization. The severity of OSM
(iPTH) rarely has been described in NS [2, 6, 8, 11].measured by mineralization lag time correlated linearly with
the duration (r 5 0.94, P , 0.0001) and the amount (r 5 0.97, Few data are available on the biological consequences
P , 0.0001) of proteinuria. All patients with NS for more than of these disturbances in calcium and vitamin D metabo-
three years had histological changes. Patients with OSM had lism. Controversy exists about the frequency and typelower 25(OH)D and serum albumin as compared with those
of bone lesions in patients with NS at a normal level ofwith normal histology (P , 0.005). Bone mineralization had
renal function. Histologic features of osteitis fibrosa orno significant correlation with serum iPTH, divalent ions, or
vitamin D levels. osteomalacia (OSM) have been found in none [12, 13],
a few [4], or all [8] of the patients in the limited number
of published studies. The purpose of this study was: (a)Key words: vitamin D, PTH, osteomalacia, calcium, proteinuria, meta-
bolic bone disease. to study bone histology in adult patients with NS and
normal renal function, (b) to analyze and quantitate boneReceived for publication June 12, 1998
mineralization, and (c) to evaluate the correlation be-and in revised form November 3, 1998
Accepted for publication November 25, 1998 tween bone mineralization, and divalent ions, iPTH, or
vitamin D levels. 1999 by the International Society of Nephrology
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METHODS methacrylate without prior decalcification. The speci-
mens were then cut into 5 to 10 mm sections using aPatients
Jung X microtome model 1140 (Jung Inc., Heidelberg,
We studied 30 patients with NS (defined as persistent Germany) and stained using the modified Villanueva-
proteinuria of more than 3.5 g/1.73 m2/24 hr, hypoalbumi- Gomori trichrome technique. The stained sections were
nemia and edema) with normal renal function (creatinine examined under a Zeiss photomicroscope with magnifi-
clearance of more than 85 ml/min on at least two occa- cation of 340, and micromorphometric measurements
sions). There were 20 men and 10 women, with an age were obtained with the help of Morphomat-30 (Zeiss,
range of 15 to 60 years (mean age of 27.3 6 11.7). The Jena, Germany). Unstained sections of 10 mm thickness
diagnosis of glomerular disease was histologically proven were evaluated under a fluorescence microscope (using
in 20 patients: minimal change disease (8 patients), focal a Zeiss multipurpose lamp with a 100 watt bulb) to assess
glomerulosclerosis (4 patients), mesangial proliferative tetracycline uptake. Both the static and dynamic parame-
glomerulonephritis (3 patients), mesangiocapillary glo- ters of bone mineralization were expressed using the
merulonephritis (3 patients), membranous nephropathy notation recommended by the American Society for
(1 patient), and amyloidosis (1 patient). Bone and Mineral Research [16]. Static parameters mea-
Patients who were taking steroids, nonsteroidal anti- sured were: (a) bone volume (BV/TV%), (b) osteoid
inflammatory drugs, anticonvulsants, or vitamin D ana- surface (OS/BS%), (c) osteoid volume (OV/BV%), (d)
logues within the past three months were excluded. Di- osteoid thickness (O.Th, mm), (e) osteoblast surface
uretics and oral calcium supplements were withdrawn at (Ob.S/BS%), (f) eroded surface (ES/BS%), (g) osteo-
least two weeks before entry. A detailed dietary history clast surface (Oc.S/BS%), and (h) osteoclast number
(N.Oc/T.A/mm2). Dynamic parameters included the fol-was taken, and severely malnourished patients, as well
lowing: (a) mineral apposition rate (MAR; mm/day), (b)as patients on a strictly vegetarian diet, were excluded.
mineralization lag time (MLt, days), and (c) bone forma-All patients were started on a diet containing 1 g of
tion rate (BFR/BS, mm3/mm2/day).calcium, 1 to 1.2 g of phosphorus, and 4 g of salt beginning
Normal values for the previously mentioned histomor-three weeks before the study. All patients were ambula-
phometric parameters were determined from iliac cresttory and had similar sun exposure.
bone biopsies done in 30 age- and sex-matched controls.
Biochemistry and radiology Controls included healthy volunteers, victims of sudden
death in road traffic accidents, or patients who had un-A detailed history and physical examination were per-
dergone orthopedic surgery for conditions not associatedformed in every case. Samples of blood for biochemical
with metabolic bone disease. All control subjects wereanalysis were obtained at the time of bone biopsy. Serum
physically active and well nourished prior to biopsy.levels of urea, creatinine, total protein, albumin, calcium,
None had received vitamin D preparations, corticoste-phosphorus, and alkaline phosphatase were determined
roids, or anticonvulsant medications or had a historyby methods adapted to the Technicon autoanalyzer (Tech-
of diabetes mellitus, renal disease, or gastrointestinalnicon Instruments Corp., Tarrytown, NY, USA). Serum
disease. The mean age of these control subjects wasionized calcium was measured using a calcium electrode
28.9 6 10.1 years (range 14 to 54). Eighteen were men,(Orion SS-20; Orion Research Inc., Cambridge, MA,
and 12 were women. The histomorphometric data ofUSA). The intact molecule iPTH was determined by im-
nephrotic patients were presented in the conventionalmunoradiometric whole molecule “sandwich” assay (Nich-
manner, as well as Z scores in order to relate them tools Allegro). Serum levels of 25(OH)D and 1,25(OH)2D normal values derived from controls. A Z score of 11
were measured by methods described previously [14, 15]. or 21 indicates a value of 11 or 21 sd from the normal
Twenty-four hour urine collections were obtained for mean. This is necessary in view of the fact that normal
the measurement of protein excretion, calcium excretion ranges for these histomorphometric measurements differ
and creatinine clearance. A metabolic bone survey com- significantly according to age and sex [17].
prising plain radiographs of hands, chest/clavicle, lateral The patients were classified into four groups on the
lumbar and thoracic spine, and pelvis was obtained in basis of histomorphometric analysis: (a) normal histol-
each patient. ogy, defined as static and dynamic parameters of ,2 sd
above or below the normal mean; (b) OSM, defined asBone biopsy and histomorphometry the presence of thickened osteoid seams and increased
All patients received time-spaced double tetracycline osteoid volume (.2 sd above the normal mean) but with
labeling, allowing a 14-day interval between the two a decreased BFR (.2 sd below the normal mean) in the
courses, with the second course ending three days before absence of any tissue fibrosis. OSM was classified as
the bone biopsy. Anterior transiliac bone biopsies were severe if the corresponding values were 3 sd above or
obtained under local anesthesia as an outpatient proce- below the normal mean; (c) osteitis fibrosa, defined as
dure. Bone specimens were fixed serially in increasing osteoid surface % .2–3 sd above the normal mean along
with presence of marrow fibrosis, plus either increasedconcentrations of alcohol and were embedded in methyl
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osteoclast surface (.2 sd above the normal mean) or an
increased osteoclast number (.20/mm2); and (d) mixed
histology (evidence of defective mineralization along
with increased bone resorption), defined as increased
eroded surface and/or osteoclast surface (.2 sd above
the normal mean) and/or an increased osteoclast number
(.20/mm2) without bone marrow fibrosis, coexisting
with a mineralization defect with or without decreased
bone formation.
Statistical analysis
All results are expressed as mean 6 standard devia-
tion. Individual histomorphometric data are also pre-
sented as Z scores (the number of standard deviations
above or below the mean of age- and sex-matched nor-
mal values), with values greater than 10 sd from the
mean truncated to equal 6 10. Unpaired t-test was used
to compare histomorphometrical parameters among
groups. The Kruskal–Wallis analysis of variance test Fig. 1. Prevalence of bone abnormalities in the normal, osteomalacia
(OSM) and OSM 1 osteitis fibrosa (OF) groups (N 5 30).(also known as analysis of variance on the ranks) was
used for comparison between groups with unequal
within-group variances. A possible relationship between
biochemical and histomorphometrical variables was ana- tween 25(OH)D levels and serum ionized calcium. Out
lyzed by calculation of Pearson’s correlation coefficient. of 30 patients, 19 had hypocalciuria. The mean urine
A P value , 0.05 was considered statistically significant. calcium excretion on a normal diet was 82 6 21 mg/day.
All patients were fully aware of the nature of investiga-
tions and gave their informed consent for bone biopsies. Bone histomorphometry
The study was approved by the institutional review board. Osteomalacia (group 2) was the most common histo-
logical finding, being present in 17 of 30 patients (56.7%;
RESULTS Fig. 1 and Table 1). Three patients (10%) had mixed
bone histology (group 4), with findings of defective min-Biochemistry
eralization associated with an increased bone resorptionAll patients had proteinuria in the nephrotic range,
but without any marrow fibrosis. The remaining 10 pa-with a mean urine protein excretion of 7.3 6 3.2 g/24 hr
tients (33.3%) had normal bone histology (group 1).and mean serum albumin of 2.2 6 0.8 g/dl. The glomeru-
Bone resorption or osteitis fibrosa (group 3) was notlar filtration rate assessed by creatinine clearance was
present as an isolated finding. Isolated OSM (group 2)normal in all patients studied (mean 103 6 4 ml/min).
was associated with significantly higher osteoid volumeThe apparent duration of NS ranged from 6 to 96 months
and thickness (P , 0.05) as compared with both healthy(mean 35.3 6 26.9). Although serum calcium was low
controls (group 1) and patients with mixed histology(mean 7.8 6 0.8 mg/dl) in 73.3% of patients, the ionized
(group 4). The MAR and BFR were significantly lowerfraction was normal (mean 5.7 6 0.7 mg/dl) in all except
(P , 0.01) in group 2 as compared with group 4. Patientstwo patients. Serum iPTH (intact molecule PTH) levels
with isolated OSM had a higher MLt (P , 0.05) com-were normal in all patients (mean 8.9 6 1.2 pg/ml), except
pared with those with associated resorption (Table 1).the two with diminished serum ionized calcium levels in
The degree of OSM was classified as mild in 13 andwhom it was mildly elevated. Ionized serum calcium
severe in 7 patients. Of seven patients with severe OSM,levels correlated inversely with serum iPTH levels (r 5
the BFR in three patients was unmeasurably low (none20.23, P , 0.05). Serum alkaline phosphatase and phos-
or single tetracycline uptake), with an MLt approachingphorus levels were in the normal range (means 149 6
infinity (Figs. 2 and 3). This emphasizes the highly inac-48.6 U/liter, 3.2 6 1.2 mg/dl, respectively) in the majority
tive bone cells in patients with severe OSM.(93.3 and 82.9%, respectively) of patients. All patients
Nine out of 30 patients had been treated with oralhad low levels of 25(OH)D, with a mean value of 3.9 6
prednisone (mean dose 24.9 6 14.9 mg/day), and one of1.2 ng/ml (normal 15 to 30). Blood levels of 1,25(OH)2D
these had also received parenteral doses of methylpred-were normal in 25 of 30 patients, with a mean of 24 6
nisolone (15 mg/kg/day 33 days). The mean duration of4.7 pg/ml (normal 16 to 65). Serum levels of 25(OH)D
steroid therapy was 4.5 6 3.2 months, whereas steroidscorrelated inversely and significantly with the amount of
were completely withdrawn three months prior to boneproteinuria (r 5 20.42, P , 0.05) but not with its dura-
tion (P 5 NS). There was no significant correlation be- biopsy in all patients. There was a trend toward lower
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Table 1. Comparison of histomorphometric parameters in various groups
Normal (group 1) Osteomalacia (group 2) Mixed (group 4)
Histological parameter N 5 10 N 5 17 N 5 3
Static parameters
Bone % 23.5161.7 (1.20 60.22) 20.9564.83 (20.4960.39) 21.2465.73 (20.5260.35)
Osteoid surface % 15.2665.42 (0.67 60.18) 72.51612.2 (3.14 62.45) 13.15614.9 (0.39 61.87)
Osteoid volume % 1.9160.81 (0.81 60.07) 19.6968.32 (5.28 62.35) 1.4662.9 (0.47 60.98)
Osteoid thickness lm 9.2161.91 (1.55 60.19) 31.8469.87 (4.39 61.98) 8.4964.81 (20.2960.27)
Osteoblast surface % 5.862.3 (0.81 60.08) 4.9261.74 (0.69 60.35) 5.1160.92 (0.73 60.43)
Eroded surface % 2.5961.61 (0.7 60.25) 2.9460.92 (0.89 61.01) 4.8461.32 (2.89 61.37)
Osteoclast surface % 0.4360.34 (1.11 60.15) 0.4760.15 (1.29 60.21) 1.8560.28 (3.21 61.21)
Osteoclast number /mm2 5.963.5 (3.7 64.12) 6.3560.72 (4.21 63.91) 28.165.2 (25.26 68.8)
Dynamic parameters
Mineral apposition rate lm/day 0.8660.12 (1.12 60.22) 0.2160.32 (24.8262.11) 0.5860.2 (23.9860.7)
Mineralization lag time days 24.6639.7 (1.21 61.03) 292680.7 (5.82 62.99)a 89631.7 (2.77 61.38)
Bone formation rate lm3/lm2/day 1.5460.8 (1.24 60.04) 0.3960.12 (22.7760.81)b 0.8961.35 (21.9860.4)
Values in parentheses indicate “z” scores (number of standard deviations above or below the normal mean).
a Does not include 3 patients with values approaching infinity
b Does not include 3 patients with immeasurable low values
Fig. 2. Photomicrograph (3100) of a section of cortical bone showing very prominent and wide osteoid seams lining both the haversian canal
and the entire trabecular surface, suggestive of severe osteomalacia.
bone volume (BV/TV%) and lower BFR in steroid- mon in females (87.5%) compared with males (59.1%).
There was no relationship between the etiology of NStreated versus untreated patients (P , 0.1). The mean
dose of prednisone was inversely correlated to BFR (r 5 and the specific histologic abnormality identified. The
severity of OSM, as determined by MLt, correlated lin-20.69, P , 0.05). None of the other static or dynamic
histomorphometric determinations were, however, af- early and significantly with the duration (r 5 0.94, P ,
0.0001; Fig. 4) and the amount of proteinuria (r 5 0.97,fected by prior steroid therapy (data not shown).
Bone abnormalities did not show a predilection for P , 0.0001; Fig. 5). All patients with NS for three years
or more (N 5 14) had abnormal bone histology.any specific age group, although lesions were more com-
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Fig. 3. Photomicrograph (340) obtained after double tetracycline labeling, showing a single, wide, and diffuse fluorescent label, suggestive of
severe osteomalacia.
Biochemical parameters in relation to bone histology Skeletal survey was reported as normal in all the pa-
tients, regardless of histological findings.The results of biochemical determinations in the pa-
tients according to their bone histologies are outlined in
Table 2. We used the Kruskal–Wallis test to compare DISCUSSION
the values in different groups. This test was used to blunt It has long been known that a state of vitamin D
the effect of widely different standard deviations within deficiency exists in patients with NS because of the loss
and among different groups. Patients with OSM (group of vitamin D metabolites in the urine [3, 4, 7–9, 11,
2) had significantly lower 25(OH)D (P , 0.0005) and 18]. A low blood concentration of ionized calcium and
serum albumin (P , 0.005) and higher urinary protein modest elevations in the blood level of iPTH have also
excretion (P , 0.0005) levels as compared with groups been reported [2, 6–8]. Indirect evidence exists that bone
1 and 4. By using Tukey’s pair-wise multiple comparison metabolism is disturbed in these patients as a result of
test, we found only groups 1 and 2 to be different (P , vitamin D deficiency and secondary hyperparathyroid-
0.05) for each of these three variables. There were too ism, even with normal renal function. Radiographic evi-
few patients in group 4 to have any significant role. dence of bone demineralization, sometimes interpreted
We further tried to correlate divalent ions and vitamin as osteoporosis, has been reported in nephrotic children
D metabolites with histomorphometric measurements. [19, 20] as well as adults [21]. Jones et al found that
Neither static nor dynamic parameters correlated (P 5 nephrotic patients retained a higher fraction of infused
NS) with serum iPTH, ionized calcium levels, phospho- calcium load as compared with normal subjects, thus
rus, alkaline phosphatase, vitamin D metabolites, or uri- consistent with the presence of OSM [21]. Reports of
bone histological changes in patients with NS, beforenary calcium excretion levels (data not shown).
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Fig. 5. Relationship between the amount of proteinuria and mineral-
ization lag time (r 5 0.97, P , 0.0001).Fig. 4. Relationship between the apparent duration of nephrotic syn-
drome (NS) and mineralization lag time (MLT; r 5 0.94, P , 0.0001).
Table 2. Biochemical analysis according to bone histology
Normal histology Osteomalacia Mixed
(group 1) (group 2) (group 3)
Biochemical variable N 5 10 N 5 17 N 5 3 P
Serum
Total calcium (9–10.5 mg/dl) 7.4 60.6 8.1 60.9 7.2 60.6 0.10
Ionized calcium (4.5–5.6 mg/dl) 5.6 60.9 5.7 60.6 5.7 60.6 0.99
Inorganic phosphorus (3–4.5 mg/dl) 3.461.4 3.2 61.1 3.1 60.7 0.99
Alkaline phosphatase (30–120 U/liter) 149649 144 650 179 623 0.57
25(OH)D (15–60 ng/ml) 5.160.7 3.2 60.9 3.9 60.6 0.0001
1,25(OH)D (16–65 pg/ml) 23.765 24.2 64.9 24 64.4 0.98
Serum albumin (3.5–5.5 g/dl) 2.9 60.5 1.9 60.7 2.2 60.8 0.003
iPTH (10–65 pg/ml) 8.761.7 9 61.2 8.960.9 0.56
Urine
Calcium (150–200 mg/day) 85.1617.4 77.6 623.7 96.7 61.5 0.23
Protein (,150 mg/day) 4.760.8 8.9 63.7 6.8 61 0.0002
P values were calculated by Kruskal-Wallis analysis of variance.
the development of renal insufficiency, are scarce and time of bone biopsy in their patients [4, 12]. This might
have prevented the full expression of biochemical abnor-conflicting (Table 3) [4, 8, 12, 13].
Our data on the largest series of patients with NS malities detected in these studies, that is, low levels of
vitamin D3 in a range usually believed to cause OSMand normal renal function reveal a higher incidence of
isolated OSM (56.7%) in comparison with other reports [4] and negative calcium balance [12]. The degree and
duration of proteinuria are likely critical factors in de-(Table 2). Increased bone resorption associated with de-
fective mineralization was a finding in another 10% of termining secondary abnormalities of mineral homeosta-
sis in NS [3]. With unabated and progressive proteinuria,our patients (Fig. 1). The mean duration of NS prior to
bone biopsy was higher (34.6 6 27.6) in our patients as these patients may eventually manifest both biochemical
and histomorphometric evidence of OSM with or with-compared with most other reported series (Table 2). Of
note, a significant linear correlation existed between MLt out bone resorption, prior to decline in glomerular filtra-
tion rate. Accordingly, patients with NS for more thanand duration (Fig. 4) and the amount (Fig. 5) of protein-
uria in our patients. The lower prevalence of OSM re- three years had universal bone involvement in this series.
Contrary to that mentioned earlier in this article, Korkorported by Tessitore et al and Lim et al could be due to
the relatively shorter duration of NS (Table 2) at the et al reported a normal bone histology in spite of reduced
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Table 3. Comparison of bone histology and various biochemical parameters in reported series of bone histology in patients with
nephrotic syndrome and normal renal function
Lim et al Malluche Korkor Tessitore Present
[12] et al [8] et al [13] et al [4] study
Number of patients 7 6 6 29 30
Age years 2062.1 22.563.4 40611.5 18–58 27.3611.7
Duration of NS months 5.964.7 $1 80.4 639.6 #3 35.5 626.9
Proteinuria g/24 hr 7.463.6 9.464.6 8.464.4 8.160.8 7.363.2
CCr ml/min 89.668 113.7629.3 101618.5 10364.1 10364
Total Ca11 mg/dl ↓(7.660.2) ↓(8.160.1) ↓(8.660.3) ↔(8.260.1) ↓(7.860.8)
Ionized Ca11 mg/dl ND ↓(3.860.2) ↔(4.660.1) ↓ ↔(5.760.7)
Phosphorus mg/dl ↔(4.660.3) ↔(3.960.7) ↔(3.960.4) ↓(3.160.2) ↔(3.261.2)
SAP U/liter ND ND ↔(76612) ND ↔(149648.6)
iPTH pg/ml ND ↑(54.7622.9) ↔(5.162.3) ↔(2.160.2) ↔(8.961.2)
25(OH)D ng/ml ND ↓(4.260.7) ↔(8.864) ↓(3.362.2) ↓(3.961.2)
1,25(OH)2D pg/ml ND ND ↔(38625) ↔(37.365.2) ↔(2464.7)
Urine Ca11 mg/day ↓(0.460.5) ND ND ND ↓(82621.2)
Bone radiology Normal ND Normal ND Normal
Bone biopsy
Normal % 85.7 0 100 76 33.3
Isolated OSM % 0 50 0 17 56.7
Mixed % 0 50 0 7 10
Other % 14.3 0 0 0 0
Symbol (↓, ↑ and ↔) denote decreased, increased and normal as compared to the normal laboratory values. Abbreviations are: CCr, creatinine clearance; Ca11,
calcium; iPTH, immunoreactive parathyroid hormone; NS, nephrotic syndrome; ND, not done; OSM, osteomalacia; SAP, serum alkaline phosphatase.
levels of vitamin D in patients with prolonged NS [13]. hyperparathyroidism. Of note, greater degrees of protein-
uria and lower serum albumin have been associated withThe number of patients, however, was too small to draw
any firm conclusions. low serum ionized calcium levels with biochemical evi-
dence of secondary hyperparathyroidism [2]. However,Despite marked abnormalities on bone biopsy, pa-
tients in this series had normal serum ionized calcium one wonders about the bone findings in those patients.
It is interesting that the mean total serum calcium aslevels and demonstrated no biochemical evidence of sec-
ondary hyperparathyroidism. Serum ionized calcium lev- well as the 24-hour urine calcium was found to be low
in spite of the presence of normal serum ionized calciumels were normal in spite of low levels of 25(OH)D. At-
tempts to estimate serum-ionized calcium by previous levels in this series. A low serum total calcium level in
the nephrotic state has generally been attributed to ainvestigators in patients with NS and normal renal func-
tion have yielded low [7, 22], normal [3, 9], or high [20] reduction in the protein-bound fraction of serum cal-
cium, associated with hypoalbuminemia, with the as-values. Increased levels of circulating iPTH, possibly a
reflection of skeletal resistance to the calcemic action of sumption that biologically important serum ionized cal-
cium is normal. In spite of normal serum ionized calciumiPTH or impaired intestinal calcium absorption, have
been described previously [2, 6–8]. Malluche, Goldstein levels, approximately two-thirds of our patients had hy-
pocalciuria. We are not sure about the biological signifi-and Massry reported a 50% prevalence of active bone
resorption associated with high iPTH levels in their ne- cance of these biochemical abnormalities. Thus, Lim et
al, despite finding low urinary calcium excretion and totalphrotic patients [8]. Others, like us, have reported both
normal levels of ionized calcium along with normal se- serum calcium levels, did not find OSM on bone biopsy
[12]. As previously mentioned, the relatively shorter du-rum iPTH in patients with NS at normal levels of renal
function [3, 13]. Active bone resorption was associated ration of proteinuria in their patients could have ac-
counted for the discrepant results.with defective mineralization in only 10% of our patients.
The apparent conflicting results in iPTH and serum ion- There is enough evidence that a loss of 25(OH)D in
the urine of nephrotic patients results in its deficiencyized calcium values may be related to differences in pa-
tient populations or differing conditions under which the [18]. This vitamin D-deficient state may underline the
deranged calcium metabolism and OSM observed inmeasurements were made. In this series, we tried to ex-
clude all possible factors that are known to affect serum these patients. Our finding of normal levels of 1,25(OH)2D
in association with reduced concentrations of 25(OH)Dionized calcium. Our results are in accord with those of
Lambert et al, whose patients were similar to our patients confirms previous reports in nephrotics with normal re-
nal function [4, 13]. Severe OSM secondary to vitaminwith respect to duration and the amount of proteinuria
[3]. Despite marked abnormalities in circulating vitamin D deficiency can occur when plasma 1,25(OH)2D con-
centration is either normal or high [23]. This phenome-D metabolites, their patients also had normal serum ion-
ized calcium and demonstrated no evidence of secondary non has been well described in patients with nutritional
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3. Lambert PW, Deoreo PB, Fu IY, Kaetzel DM, Vonahn K, Hol-OSM [24] and on anticonvulsant therapy [25]. As Korkor
lis BW, Roos BA: Urinary and plasma vitamin D3 metabolites inet al hypothesized, the normal levels of 1,25(OH)2D in the nephrotic syndrome. Metab Bone Dis Relat Res 4:7–15, 1982
nephrotic patients could be a result of maintenance of 4. Tessitore N, Bonucci E, D’Angelo A, Lund B, Corgnati A,
Lund B, Valvo E, Lupo A, Loschiavo C, Fabris A, Maschio G:normal free 25(OH)D levels in a way analogous to that
Bone histology and calcium metabolism in patients with nephroticof normal serum free T4 [13]. syndrome and normal or reduced renal function. Nephron 37:153–
Low levels of 25(OH)D in the current investigation 159, 1984
correlated inversely with the amount of proteinuria but 5. Alon U, Chan JCM: Calcium and vitamin D homeostasis in the
nephrotic syndrome: Current status. Nephron 36:1–4, 1984had no significant correlation with either the duration
6. Freundlich M, Bourgoignie JJ, Zilleruelo G, Abitbol C, Cant-or the extent of bone mineralization. OSM as a predomi-
erbury JM, Strauss J: Calcium and vitamin D metabolism in
nant finding in the presence of normal divalent ions, as children with nephrotic syndrome. J Pediatr 108:383–387, 1986
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